Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014271736> ?p ?o ?g. }
- W2014271736 endingPage "258" @default.
- W2014271736 startingPage "247" @default.
- W2014271736 abstract "Abstract Background Although the molecular mechanism of androgen‐independent prostate cancer growth and progression has been gradually elucidated, there is limited effective treatment for this prevalent disease. Human prostatic acid phosphatase (PAcP), a major protein tyrosine phosphatase in prostate epithelium, plays a critical role in regulating the growth of prostate cancer cells. In prostate carcinomas, the expression of cellular PAcP decreases. To explore directly the possible therapeutic potential of cellular PAcP, we investigated the suppression effect of PAcP by utilizing cDNA direct intratumoral administration in androgen‐independent LNCaP xenograft tumors. Methods An androgen‐independent LNCaP cell model (C‐33 and C‐81 cells) and stable subclones of PAcP cDNA‐transfected C‐81 cells (LNCaP‐23 and LNCaP‐34 cells) were used for the experiments. We examined the growth property and expression of PAcP and c‐ErbB‐2 of these different LNCaP cells in vitro and in vivo. We subsequently investigated the growth suppression effect of PAcP cDNA intratumoral injection in pre‐established C‐81 xenograft tumors, and analyzed the expression of PAcP, prostate‐specific antigen (PSA), proliferating cell nuclear antigen (PCNA), and c‐ErbB‐2 in the tumors by immunohistochemistry and Western blotting. Results The different LNCaP cells exhibited different growth property and tumorigenicity, both in cell culture and xenograft. Biochemical characterizations revealed that the level of cellular PAcP correlated negatively with the growth property of different LNCaP cells, while the level of tyrophosphorylated c‐ErbB‐2 had an inverse correlation with cellular PAcP. The single intratumoral administration of the wild type PAcP cDNA showed a significant suppression effect on C‐81 xenograft tumor growth, compared to vector alone‐injected control ( P <0.05). In the tumors injected with this PAcP cDNA, the PAcP expression was detected 1 week (wk) after injection, but was undetectable at 6 wk, which inversely correlated with the level of tyrophosphorylated c‐ErbB‐2 and the degree of cell proliferation indicated by PCNA staining. Conclusions Our results clearly demonstrated that cellular PAcP has a suppression effect on the growth of androgen‐independent LNCaP xenograft tumors. This effect occurs at least partly through the dephosphorylation of c‐ErbB‐2 by PAcP, the prostate‐specific protein tyrosine phosphatase. The data indicates that human PAcP could be utilized in the corrective gene therapy for a subgroup of androgen‐independent human prostate cancer cells that lack cellular PAcP expression. Prostate 55: 247–258, 2003. © 2003 Wiley‐Liss, Inc." @default.
- W2014271736 created "2016-06-24" @default.
- W2014271736 creator A5021172166 @default.
- W2014271736 creator A5026534555 @default.
- W2014271736 creator A5035222810 @default.
- W2014271736 creator A5089553872 @default.
- W2014271736 date "2003-04-18" @default.
- W2014271736 modified "2023-10-14" @default.
- W2014271736 title "Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase" @default.
- W2014271736 cites W1853544818 @default.
- W2014271736 cites W1964996775 @default.
- W2014271736 cites W1966895752 @default.
- W2014271736 cites W1968491349 @default.
- W2014271736 cites W1978960998 @default.
- W2014271736 cites W1983914774 @default.
- W2014271736 cites W1985466341 @default.
- W2014271736 cites W1989752811 @default.
- W2014271736 cites W2005953810 @default.
- W2014271736 cites W2007812908 @default.
- W2014271736 cites W2009268530 @default.
- W2014271736 cites W2013474978 @default.
- W2014271736 cites W2019820185 @default.
- W2014271736 cites W2027430685 @default.
- W2014271736 cites W2056531751 @default.
- W2014271736 cites W2058507321 @default.
- W2014271736 cites W2058555457 @default.
- W2014271736 cites W2062440930 @default.
- W2014271736 cites W2068427129 @default.
- W2014271736 cites W2072685184 @default.
- W2014271736 cites W2081868968 @default.
- W2014271736 cites W2090236692 @default.
- W2014271736 cites W2091666445 @default.
- W2014271736 cites W2095141603 @default.
- W2014271736 cites W2095156669 @default.
- W2014271736 cites W2105829250 @default.
- W2014271736 cites W2127265188 @default.
- W2014271736 cites W2131931560 @default.
- W2014271736 cites W2138593266 @default.
- W2014271736 cites W2152988906 @default.
- W2014271736 cites W2157152749 @default.
- W2014271736 cites W2160427174 @default.
- W2014271736 cites W2161810908 @default.
- W2014271736 cites W2235954515 @default.
- W2014271736 cites W2315084821 @default.
- W2014271736 cites W2334127382 @default.
- W2014271736 cites W2438565249 @default.
- W2014271736 doi "https://doi.org/10.1002/pros.10240" @default.
- W2014271736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12712404" @default.
- W2014271736 hasPublicationYear "2003" @default.
- W2014271736 type Work @default.
- W2014271736 sameAs 2014271736 @default.
- W2014271736 citedByCount "24" @default.
- W2014271736 countsByYear W20142717362012 @default.
- W2014271736 countsByYear W20142717362013 @default.
- W2014271736 countsByYear W20142717362014 @default.
- W2014271736 countsByYear W20142717362016 @default.
- W2014271736 countsByYear W20142717362018 @default.
- W2014271736 countsByYear W20142717362019 @default.
- W2014271736 crossrefType "journal-article" @default.
- W2014271736 hasAuthorship W2014271736A5021172166 @default.
- W2014271736 hasAuthorship W2014271736A5026534555 @default.
- W2014271736 hasAuthorship W2014271736A5035222810 @default.
- W2014271736 hasAuthorship W2014271736A5089553872 @default.
- W2014271736 hasConcept C121608353 @default.
- W2014271736 hasConcept C126322002 @default.
- W2014271736 hasConcept C2776235491 @default.
- W2014271736 hasConcept C2776490512 @default.
- W2014271736 hasConcept C2777911890 @default.
- W2014271736 hasConcept C2779723316 @default.
- W2014271736 hasConcept C2780192828 @default.
- W2014271736 hasConcept C502942594 @default.
- W2014271736 hasConcept C55493867 @default.
- W2014271736 hasConcept C62112901 @default.
- W2014271736 hasConcept C71315377 @default.
- W2014271736 hasConcept C71924100 @default.
- W2014271736 hasConcept C86803240 @default.
- W2014271736 hasConceptScore W2014271736C121608353 @default.
- W2014271736 hasConceptScore W2014271736C126322002 @default.
- W2014271736 hasConceptScore W2014271736C2776235491 @default.
- W2014271736 hasConceptScore W2014271736C2776490512 @default.
- W2014271736 hasConceptScore W2014271736C2777911890 @default.
- W2014271736 hasConceptScore W2014271736C2779723316 @default.
- W2014271736 hasConceptScore W2014271736C2780192828 @default.
- W2014271736 hasConceptScore W2014271736C502942594 @default.
- W2014271736 hasConceptScore W2014271736C55493867 @default.
- W2014271736 hasConceptScore W2014271736C62112901 @default.
- W2014271736 hasConceptScore W2014271736C71315377 @default.
- W2014271736 hasConceptScore W2014271736C71924100 @default.
- W2014271736 hasConceptScore W2014271736C86803240 @default.
- W2014271736 hasIssue "4" @default.
- W2014271736 hasLocation W20142717361 @default.
- W2014271736 hasLocation W20142717362 @default.
- W2014271736 hasOpenAccess W2014271736 @default.
- W2014271736 hasPrimaryLocation W20142717361 @default.
- W2014271736 hasRelatedWork W1985023004 @default.
- W2014271736 hasRelatedWork W2053726955 @default.
- W2014271736 hasRelatedWork W2075763133 @default.
- W2014271736 hasRelatedWork W2088520467 @default.